Novel bivalent securinine mimetics as topoisomerase I inhibitors

MedChemComm
2017.0

Abstract

A series of novel bivalent securinine mimetics incorporating different linkers between C-15 and C-15' were synthesized and their topoisomerase I (Topo I) inhibitory activities evaluated. It was thus revealed that mimetic <b>R2</b> incorporating a rigid <i>m</i>-substituted benzene linker exhibits Topo I inhibitory activity three times that of parent securinine. Comprehensive structure-activity relationship analyses in combination with docking studies were used to rationalize the potent activity of these bivalent mimetics. Mechanistic studies served to confirm the deductions arising from docking studies that the active bivalent mimetics not only inhibited complexation between Topo I and DNA but also stabilized the Topo I-DNA complex itself.

Knowledge Graph

Similar Paper

Novel bivalent securinine mimetics as topoisomerase I inhibitors
MedChemComm 2017.0
Novel securinine derivatives as topoisomerase I based antitumor agents
European Journal of Medicinal Chemistry 2016.0
Bisindolylmaleimides Linked to DNA Minor Groove Binding Lexitropsins:  Synthesis, Inhibitory Activity against Topoisomerase I, and Biological Evaluation
Journal of Medicinal Chemistry 1996.0
Convenient synthesis of indeno[1,2-c]isoquinolines as constrained forms of 3-arylisoquinolines and docking study of a topoisomerase I inhibitor into DNA–topoisomerase I complex
Bioorganic &amp; Medicinal Chemistry Letters 2007.0
Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors
European Journal of Medicinal Chemistry 2017.0
Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors
European Journal of Medicinal Chemistry 2015.0
Design and synthesis of 4-amino-2-phenylquinazolines as novel topoisomerase I inhibitors with molecular modeling
Bioorganic &amp; Medicinal Chemistry 2011.0
Synthesis of new 3-Arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity
Bioorganic &amp; Medicinal Chemistry Letters 2003.0
Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity
European Journal of Medicinal Chemistry 2015.0
Azaindenoisoquinolines as Topoisomerase I Inhibitors and Potential Anticancer Agents: A Systematic Study of Structure–Activity Relationships
Journal of Medicinal Chemistry 2012.0